US Starts Formal Withdrawal From World Health Organization

The United States has formally notified the World Health Organization (WHO) that it intends to withdraw from the UN health agency. US officials have linked the decision to allegations about how the WHO handled the COVID-19 pandemic, including claims that the agency’s independence was compromised and that its work followed a politicized agenda.

WHO leadership has rejected those allegations. The organization said its pandemic response was evidence-based and transparent, and argued it acted within its constitutional mandate while respecting the sovereignty of all member states during the crisis.

Withdrawal notification enters WHO’s governance process

According to the timeline cited, the withdrawal notification is scheduled to be reviewed by the WHO Executive Board in February. It is then set to be considered by the World Health Assembly in May 2026.

The projected schedule means the decision now moves into the WHO’s formal governance track, where member-state bodies are expected to take up the notification on the dates indicated. The source material does not specify what procedural steps could follow those reviews or whether any additional actions are required beyond them.

Uncertainty for pandemic-era reforms and health cooperation

The planned US departure adds uncertainty to future international health cooperation, particularly around initiatives referenced in the source material. These include the implementation of the recently adopted Pandemic Agreement and the development of pathogen access and benefit-sharing systems.

In practical terms, the source highlights institutional risks that could accompany a withdrawal by a major member. Those risks include potential disruption to global health security frameworks and the loss of a primary funding and technical contributor.

WHO leaves door open to future US re-engagement

The WHO said it remains open to the possibility that the United States could re-engage in the future. The organization framed that openness as part of an effort to maintain continuity in global health governance.

Based on the information provided, a key unknown is how the withdrawal process will affect the specific workstreams tied to the Pandemic Agreement and the pathogen access and benefit-sharing arrangements over the period leading up to the February and May 2026 reviews.